SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'PPK'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1P7L_C_SAMC685_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.26A	1p7lC-5a1iA: 57.1	1p7lC-5a1iA: 54.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1P7L_C_SAMC885_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.26A	1p7lD-5a1iA: 57.2	1p7lD-5a1iA: 54.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_A_SAMA385_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.29A	1rg9A-5a1iA: 57.2	1rg9A-5a1iA: 54.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_B_SAMB485_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.29A	1rg9B-5a1iA: 57.2	1rg9B-5a1iA: 54.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_C_SAMC585_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.31A	1rg9C-5a1iA: 57.1	1rg9C-5a1iA: 54.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_C_SAMC685_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.30A	1rg9D-5a1iA: 57.2	1rg9D-5a1iA: 54.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OBV_A_SAMA501_0 (S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.20A	2obvA-5a1iA: 64.9	2obvA-5a1iA: 85.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P02_A_SAMA2_0 (S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.11A	2p02A-5a1iA: 66.8	2p02A-5a1iA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K0B_B_SAMB504_1 (S-ADENOSYLMETHIONINE SYNTHASE)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	5 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) K A 403 ( 3.0A)	0.32A	4k0bB-5a1iA: 27.0	4k0bB-5a1iA: 24.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTT_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.28A	4kttA-5a1iA: 56.3	4kttA-5a1iA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTT_C_SAMC404_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.23A	4kttC-5a1iA: 56.1	4kttC-5a1iA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTV_A_ADNA403_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	8 / 12	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.66A	4ktvA-5a1iA: 55.9 4ktvB-5a1iA: 61.7	4ktvA-5a1iA: 100.00 4ktvB-5a1iA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTV_C_ADNC403_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	7 / 11	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.46A	4ktvC-5a1iA: 55.6 4ktvD-5a1iA: 62.0	4ktvC-5a1iA: 100.00 4ktvD-5a1iA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L7I_B_SAMB501_1 (S-ADENOSYLMETHIONINE SYNTHASE)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	5 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) K A 403 ( 3.0A)	0.33A	4l7iB-5a1iA: 26.4	4l7iB-5a1iA: 24.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NDN_A_SAMA407_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.21A	4ndnA-5a1iA: 56.7	4ndnA-5a1iA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NDN_C_SAMC405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	7 / 7	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.17A	4ndnC-5a1iA: 56.6	4ndnC-5a1iA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ODJ_A_SAMA500_0 (S-ADENOSYLMETHIONINE SYNTHASE)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	7 / 7	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.25A	4odjA-5a1iA: 60.2	4odjA-5a1iA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5A1I_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	7 / 7	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.01A	5a1iA-5a1iA: 68.5	5a1iA-5a1iA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T8S_B_SAMB402_1 (S-ADENOSYLMETHIONINE SYNTHASE)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.19A	5t8sB-5a1iA: 54.9	5t8sB-5a1iA: 56.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FBN_B_SAMB401_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.23A	6fbnB-5a1iA: 54.6	6fbnB-5a1iA: 99.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FBO_A_ADNA406_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.09A	6fboA-5a1iA: 66.2	6fboA-5a1iA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FBP_B_ADNB404_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	8 / 12	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.19A	6fbpA-5a1iA: 63.4 6fbpB-5a1iA: 56.7	6fbpA-5a1iA: 100.00 6fbpB-5a1iA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FCB_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.26A	6fcbA-5a1iA: 64.1	6fcbA-5a1iA: 99.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FCD_A_ADNA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 ( 3.9A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.07A	6fcdA-5a1iA: 65.7	6fcdA-5a1iA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6G6R_A_SAMA406_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	5a1i	S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (Homo sapiens)	7 / 7	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 247 PHE A 250 ASP A 258	SAM A 405 ( 3.6A) SAM A 405 (-4.0A) ADN A 407 (-2.8A) PPK A 400 ( 2.6A) ADN A 407 (-2.7A) SAM A 405 (-3.4A) K A 403 ( 3.0A)	0.04A	6g6rA-5a1iA: 66.9	6g6rA-5a1iA: 100.00

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1P7L_C_SAMC685_0","S-ADENOSYLMETHIONINE SYNTHETASE","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.26A","1p7lC-5a1iA:57.1",null],["1P7L_C_SAMC885_1","S-ADENOSYLMETHIONINE SYNTHETASE","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.26A","1p7lD-5a1iA:57.2","1p7lC-5a1iA:54.84"],["1RG9_A_SAMA385_0","S-ADENOSYLMETHIONINE SYNTHETASE","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.29A","1rg9A-5a1iA:57.2","1p7lD-5a1iA:54.84"],["1RG9_B_SAMB485_1","S-ADENOSYLMETHIONINE SYNTHETASE","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.29A","1rg9B-5a1iA:57.2","1rg9A-5a1iA:54.84"],["1RG9_C_SAMC585_0","S-ADENOSYLMETHIONINE SYNTHETASE","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.31A","1rg9C-5a1iA:57.1","1rg9B-5a1iA:54.84"],["1RG9_C_SAMC685_1","S-ADENOSYLMETHIONINE SYNTHETASE","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.30A","1rg9D-5a1iA:57.2","1rg9C-5a1iA:54.84"],["2OBV_A_SAMA501_0","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.20A","2obvA-5a1iA:64.9","1rg9D-5a1iA:54.84"],["2P02_A_SAMA2_0","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.11A","2p02A-5a1iA:66.8","2obvA-5a1iA:85.68"],["4K0B_B_SAMB504_1","S-ADENOSYLMETHIONINE SYNTHASE","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",5,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);  K A 403 ( 3.0A)","0.32A","4k0bB-5a1iA:27.0","2p02A-5a1iA:100.00"],["4KTT_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.28A","4kttA-5a1iA:56.3","4k0bB-5a1iA:24.84"],["4KTT_C_SAMC404_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.23A","4kttC-5a1iA:56.1","4kttA-5a1iA:100.00"],["4KTV_A_ADNA403_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2;S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.66A","4ktvA-5a1iA:55.9;4ktvB-5a1iA:61.7","4kttC-5a1iA:100.00"],["4KTV_C_ADNC403_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2;S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.46A","4ktvC-5a1iA:55.6;4ktvD-5a1iA:62.0","4ktvA-5a1iA:100.00;4ktvB-5a1iA:100.00"],["4L7I_B_SAMB501_1","S-ADENOSYLMETHIONINE SYNTHASE","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",5,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);  K A 403 ( 3.0A)","0.33A","4l7iB-5a1iA:26.4","4ktvC-5a1iA:100.00;4ktvD-5a1iA:100.00"],["4NDN_A_SAMA407_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.21A","4ndnA-5a1iA:56.7","4l7iB-5a1iA:24.84"],["4NDN_C_SAMC405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.17A","4ndnC-5a1iA:56.6","4ndnA-5a1iA:100.00"],["4ODJ_A_SAMA500_0","S-ADENOSYLMETHIONINE SYNTHASE","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.25A","4odjA-5a1iA:60.2","4ndnC-5a1iA:100.00"],["5A1I_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.01A","5a1iA-5a1iA:68.5","4odjA-5a1iA:56.28"],["5T8S_B_SAMB402_1","S-ADENOSYLMETHIONINE SYNTHASE","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.19A","5t8sB-5a1iA:54.9","5a1iA-5a1iA:100.00"],["6FBN_B_SAMB401_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.23A","6fbnB-5a1iA:54.6","5t8sB-5a1iA:56.05"],["6FBO_A_ADNA406_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.09A","6fboA-5a1iA:66.2","6fbnB-5a1iA:99.75"],["6FBP_B_ADNB404_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.19A","6fbpA-5a1iA:63.4;6fbpB-5a1iA:56.7","6fboA-5a1iA:100.00"],["6FCB_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.26A","6fcbA-5a1iA:64.1","6fbpA-5a1iA:100.00;6fbpB-5a1iA:100.00"],["6FCD_A_ADNA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 ( 3.9A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.07A","6fcdA-5a1iA:65.7","6fcbA-5a1iA:99.75"],["6G6R_A_SAMA406_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","5a1i","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 247;PHE A 250;ASP A 258","SAM A 405 ( 3.6A);SAM A 405 (-4.0A);ADN A 407 (-2.8A);PPK A 400 ( 2.6A);ADN A 407 (-2.7A);SAM A 405 (-3.4A);  K A 403 ( 3.0A)","0.04A","6g6rA-5a1iA:66.9","6fcdA-5a1iA:100.00"]]